Report Detail
Global (United States, European Union and China) Hip Osteoarthritis Pain Medicine Market Research Report 2019-2025
- RnM3704248 |
- 28 August, 2019 |
- Global |
- 126 Pages |
- QYResearch |
- Pharma & Healthcare
Hip Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.
In 2019, the market size of Hip Osteoarthritis Pain Medicine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 5.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hip Osteoarthritis Pain Medicine.
This report studies the global market size of Hip Osteoarthritis Pain Medicine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Hip Osteoarthritis Pain Medicine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Market Segment by Product Type
Oral
Injection
External
Market Segment by Application
Medical Care
Personal Care
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Hip Osteoarthritis Pain Medicine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Hip Osteoarthritis Pain Medicine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Hip Osteoarthritis Pain Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Oral
- 1.3.3 Injection
- 1.3.4 External
- 1.4 Market Segment by Application
- 1.4.1 Global Hip Osteoarthritis Pain Medicine Market Share by Application (2019-2025)
- 1.4.2 Medical Care
- 1.4.3 Personal Care
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Hip Osteoarthritis Pain Medicine Market Size
- 2.1.1 Global Hip Osteoarthritis Pain Medicine Revenue 2014-2025
- 2.1.2 Global Hip Osteoarthritis Pain Medicine Sales 2014-2025
- 2.2 Hip Osteoarthritis Pain Medicine Growth Rate by Regions
- 2.2.1 Global Hip Osteoarthritis Pain Medicine Sales by Regions 2014-2019
- 2.2.2 Global Hip Osteoarthritis Pain Medicine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Hip Osteoarthritis Pain Medicine Sales by Manufacturers
- 3.1.1 Hip Osteoarthritis Pain Medicine Sales by Manufacturers 2014-2019
- 3.1.2 Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Hip Osteoarthritis Pain Medicine Revenue by Manufacturers (2014-2019)
- 3.2.2 Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Hip Osteoarthritis Pain Medicine Market Concentration Ratio (CR5 and HHI)
- 3.3 Hip Osteoarthritis Pain Medicine Price by Manufacturers
- 3.4 Key Manufacturers Hip Osteoarthritis Pain Medicine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Hip Osteoarthritis Pain Medicine Market
- 3.6 Key Manufacturers Hip Osteoarthritis Pain Medicine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Oral Sales and Revenue (2014-2019)
- 4.1.2 Injection Sales and Revenue (2014-2019)
- 4.1.3 External Sales and Revenue (2014-2019)
- 4.2 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type
- 4.3 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type
- 4.4 Hip Osteoarthritis Pain Medicine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Hip Osteoarthritis Pain Medicine Sales by Application
6 United States
- 6.1 United States Hip Osteoarthritis Pain Medicine Breakdown Data by Company
- 6.2 United States Hip Osteoarthritis Pain Medicine Breakdown Data by Type
- 6.3 United States Hip Osteoarthritis Pain Medicine Breakdown Data by Application
7 European Union
- 7.1 European Union Hip Osteoarthritis Pain Medicine Breakdown Data by Company
- 7.2 European Union Hip Osteoarthritis Pain Medicine Breakdown Data by Type
- 7.3 European Union Hip Osteoarthritis Pain Medicine Breakdown Data by Application
8 China
- 8.1 China Hip Osteoarthritis Pain Medicine Breakdown Data by Company
- 8.2 China Hip Osteoarthritis Pain Medicine Breakdown Data by Type
- 8.3 China Hip Osteoarthritis Pain Medicine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Hip Osteoarthritis Pain Medicine Breakdown Data by Company
- 9.2 Rest of World Hip Osteoarthritis Pain Medicine Breakdown Data by Type
- 9.3 Rest of World Hip Osteoarthritis Pain Medicine Breakdown Data by Application
- 9.4 Rest of World Hip Osteoarthritis Pain Medicine Breakdown Data by Countries
- 9.4.1 Rest of World Hip Osteoarthritis Pain Medicine Sales by Countries
- 9.4.2 Rest of World Hip Osteoarthritis Pain Medicine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.1.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Johnson & Johnson
- 10.2.1 Johnson & Johnson Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.2.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.2.5 Johnson & Johnson Recent Development
- 10.3 GlaxoSmithKline
- 10.3.1 GlaxoSmithKline Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.3.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.3.5 GlaxoSmithKline Recent Development
- 10.4 Bayer
- 10.4.1 Bayer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.4.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.4.5 Bayer Recent Development
- 10.5 Eli Lilly
- 10.5.1 Eli Lilly Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.5.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.5.5 Eli Lilly Recent Development
- 10.6 Novartis
- 10.6.1 Novartis Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.6.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.6.5 Novartis Recent Development
- 10.7 Sanofi
- 10.7.1 Sanofi Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.7.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.7.5 Sanofi Recent Development
- 10.8 Horizon Pharma
- 10.8.1 Horizon Pharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.8.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.8.5 Horizon Pharma Recent Development
- 10.9 Abbott
- 10.9.1 Abbott Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.9.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.9.5 Abbott Recent Development
- 10.10 Mylan
- 10.10.1 Mylan Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Hip Osteoarthritis Pain Medicine
- 10.10.4 Hip Osteoarthritis Pain Medicine Product Introduction
- 10.10.5 Mylan Recent Development
- 10.11 Daiichi Sankyo
- 10.12 TEVA
- 10.13 Almatica Pharma
- 10.14 Astellas Pharma
- 10.15 Tide Pharmaceutical
- 10.16 Iroko Pharmaceuticals
- 10.17 Hengrui Pharmaceutical
- 10.18 Abiogen Pharma
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Hip Osteoarthritis Pain Medicine Sales Channels
- 11.2.2 Hip Osteoarthritis Pain Medicine Distributors
- 11.3 Hip Osteoarthritis Pain Medicine Customers
12 Market Forecast
- 12.1 Global Hip Osteoarthritis Pain Medicine Sales and Revenue Forecast 2019-2025
- 12.2 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Type
- 12.3 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Application
- 12.4 Hip Osteoarthritis Pain Medicine Forecast by Regions
- 12.4.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Hip Osteoarthritis Pain Medicine. Industry analysis & Market Report on Hip Osteoarthritis Pain Medicine is a syndicated market report, published as Global (United States, European Union and China) Hip Osteoarthritis Pain Medicine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Hip Osteoarthritis Pain Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
